1Desmet VJ. Gerber M,Hoofnagle JH,et al.Classification of chronic hepatitis: diagnosis, grading and staging[].Hepatology.1994
2Poynard T,Bedossa P,Opolon P.Natural history of liver fibrosis progression in patients with chronic hepatitis C lancet [ J][]..1997
3Bennett WG,Inore Y,Beck JR,et al.Estimates of the cost-effectiveness of single course of interferon-α26 in patientes with histologically mild chronic hepatitis C[].Annals of Internal Medicine.1997
4Poynard T,Leroy V,Cohard M,et al.Meta- analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of doseand duration[].Hepatology.1996
5Kim JL,Morgenstern KA,Lin C,et al.Crystal structure of the hepatitis C virus NS3 protease domain complexed with a syntnetic NS4A cofactor peptide[].Cell.1996
6Arthur RR. Hassan NF,Abballah MY,et al.Hepatitis C antibody prevalence in blood donors in different govennates in Egypt[].Transactions of the Royal Society of Tropical Medicine and Hygiene.1997
7Johnson RJ. Gretch DR. Yamabe H,et al.Membranoproliferative glomerulonepnritis associated with hepatitis C virus infection[].The New England Journal of Medicine.1993
8Brillanti S,Garson J,Foli M,et al.A pilot study of Combination therapy with rubavirin plus interferon alfa for interferon alfa-resistant chronic nepatitis C[].Gastroenterology.1994
9Conry-Cantilena C,Van Raden M,Gibble J,et al.Routes of infection, viremia and liver disease in asymptomatic individuals with hepatitis C virus infection[].The New England Journal of Medicine.1996
10Davidson F,Simmonds P,Ferguson JC,et al.Survey of major genotypes and subtypes of hepatitis C virus uring RFLP of sequences amplified from the 5’noncoding region[].Journal of General Virology.1995
